Hasan A, Cavalu S, Kira A, Hamad R, Abdel-Reheim M, Elmorsy E
Int J Nanomedicine. 2025; 20():741-770.
PMID: 39845772
PMC: 11752831.
DOI: 10.2147/IJN.S502833.
Santos L, Musther H, Bala N, Deferm N, Patel G, Brouwers J
AAPS J. 2025; 27(1):31.
PMID: 39843813
DOI: 10.1208/s12248-025-01016-x.
Moratalla-Navarro F, Carreras-Torres R, Diez-Obrero V, Devall M, Obon-Santacana M, Diez-Villanueva A
Int J Mol Sci. 2024; 25(21).
PMID: 39518949
PMC: 11547083.
DOI: 10.3390/ijms252111395.
Shah S, Famta P, Vambhurkar G, Sharma A, Mourya A, Srinivasarao D
Drug Deliv Transl Res. 2024; 15(3):1074-1091.
PMID: 38995610
DOI: 10.1007/s13346-024-01657-z.
van Aken G
Front Nutr. 2024; 11:1339711.
PMID: 38606020
PMC: 11007706.
DOI: 10.3389/fnut.2024.1339711.
Evidence of Reliable Gastro-Resistance of Novel Enteric Ready-to-Fill Capsules Simplifying Pharmaceutical Manufacturing.
Afonso Urich J, Fedorko A, Holzer B, Khinast J
Pharmaceutics. 2023; 15(11).
PMID: 38004571
PMC: 10675293.
DOI: 10.3390/pharmaceutics15112592.
In Vivo Evaluation of a Gastro-Resistant Enprotect Capsule under Postprandial Conditions.
Grimm M, Rump A, Kromrey M, Morof F, Dumont C, Jannin V
Pharmaceutics. 2023; 15(11).
PMID: 38004555
PMC: 10674880.
DOI: 10.3390/pharmaceutics15112576.
Probing milk extracellular vesicles for intestinal delivery of RNA therapies.
Zhang Y, Belaid M, Luo X, Daci A, Limani R, Mantaj J
J Nanobiotechnology. 2023; 21(1):406.
PMID: 37924132
PMC: 10623793.
DOI: 10.1186/s12951-023-02173-x.
Dose-sparing effect of lapatinib co-administered with a high-fat enteral nutrition emulsion: preclinical pharmacokinetic study.
Zhu J, Xu G, Yang D, Song Y, Tong Y, Kong S
PeerJ. 2023; 11:e16207.
PMID: 37842056
PMC: 10569162.
DOI: 10.7717/peerj.16207.
Endoscopic administration of Coca-Cola for medical management of a wedged intestinal trichobezoar in a cat.
Wilson S, Dobbins D, Kawalilak L, Parambeth J
Can Vet J. 2023; 64(8):747-752.
PMID: 37529386
PMC: 10352036.
Integration of Biorelevant Pediatric Dissolution Methodology into PBPK Modeling to Predict In Vivo Performance and Bioequivalence of Generic Drugs in Pediatric Populations: a Carbamazepine Case Study.
Pawar G, Wu F, Zhao L, Fang L, Burckart G, Feng K
AAPS J. 2023; 25(4):67.
PMID: 37386339
DOI: 10.1208/s12248-023-00826-1.
Comparative genomics and phenotypic studies to determine site-specificity of in the lower gastrointestinal tract of humans.
Barua R, Pavli P, Gordon D, OBrien C
Gut Microbes. 2023; 15(1):2223332.
PMID: 37340735
PMC: 10286668.
DOI: 10.1080/19490976.2023.2223332.
Recent Advances in Pharmaceutical Approaches of Antimicrobial Agents for Selective Delivery in Various Administration Routes.
Marzaman A, Roska T, Sartini S, Utami R, Sulistiawati S, Enggi C
Antibiotics (Basel). 2023; 12(5).
PMID: 37237725
PMC: 10215767.
DOI: 10.3390/antibiotics12050822.
Effect of Food and a Proton-Pump Inhibitor on the Absorption of Encorafenib: An -- Approach.
Piscitelli J, Hens B, Tomaszewska I, Wollenberg L, Litwiler K, McAllister M
Mol Pharm. 2023; 20(5):2589-2599.
PMID: 37037186
PMC: 10155203.
DOI: 10.1021/acs.molpharmaceut.3c00016.
Regulatory utility of physiologically based pharmacokinetic modeling for assessing food impact in bioequivalence studies: A workshop summary report.
Shoyaib A, Emami Riedmaier A, Kumar A, Roy P, Parrott N, Fang L
CPT Pharmacometrics Syst Pharmacol. 2023; 12(5):610-618.
PMID: 36597353
PMC: 10196427.
DOI: 10.1002/psp4.12913.
Numerical modeling of the dissolution of drug nanocrystals and its application to industrial product development.
Bonhoeffer B, Kordikowski A, John E, Juhnke M
ADMET DMPK. 2022; 10(4):253-287.
PMID: 36578561
PMC: 9793462.
DOI: 10.5599/admet.1437.
RoboCap: Robotic mucus-clearing capsule for enhanced drug delivery in the gastrointestinal tract.
Srinivasan S, Alshareef A, Hwang A, Kang Z, Kuosmanen J, Ishida K
Sci Robot. 2022; 7(70):eabp9066.
PMID: 36170378
PMC: 10034646.
DOI: 10.1126/scirobotics.abp9066.
Intraintestinal Analysis of the Functional Activity of Microbiomes and Its Application to the Common Marmoset Intestine.
Uehara M, Inoue T, Kominato M, Hase S, Sasaki E, Toyoda A
mSystems. 2022; 7(5):e0052022.
PMID: 36005400
PMC: 9601136.
DOI: 10.1128/msystems.00520-22.
Development of a Novel Bilosomal System for Improved Oral Bioavailability of Sertraline Hydrochloride: Formulation Design, In Vitro Characterization, and Ex Vivo and In Vivo Studies.
Ismail A, Teiama M, Magdy B, Sakran W
AAPS PharmSciTech. 2022; 23(6):188.
PMID: 35799076
DOI: 10.1208/s12249-022-02339-0.
Nanoparticle modification in biological media: implications for oral nanomedicines.
Muraleetharan V, Mantaj J, Swedrowska M, Vllasaliu D
RSC Adv. 2022; 9(69):40487-40497.
PMID: 35542629
PMC: 9076262.
DOI: 10.1039/c9ra08403g.